LIPID METABOLISM CORRECTION BY ANTISENSE TECHNOLOGY
<p>Antisense oligonucleotides (ASO) technology in elaboration of drugs for lipid metabolism correction is discussed. The main ASO types and modes of its action on the target mRNA are analyzed. Advantages and disadvantages of different ASO are considered in the context of requirements for their thera...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Столичная издательская компания
2015-09-01
|
| Edice: | Рациональная фармакотерапия в кардиологии |
| Témata: | |
| On-line přístup: | http://www.rpcardio.ru/jour/article/view/229 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|